The week in health tech, explained in plain English.Get the free newsletter →
November 12, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Medicare's WISeR Prior Authorization Test Survives Senate Vote

Medicare's newest experiment in cost control just cleared its most consequential political hurdle. On July 16, the Senate voted 46-50 along party lines against advancing a resolution to end the Wasteful and Inappropriate Service Reduction Model, or WISeR, CMS's six-state test of technology-assisted prior authorization in traditional Medicare, according to Becker's Hospital Review.

WISeR matters because fee-for-service Medicare has historically had almost no prior authorization, unlike Medicare Advantage and commercial plans. The model applies AI-assisted review to a set of services CMS considers vulnerable to fraud, waste, and abuse. Democrats behind the repeal effort argued the approach would inject the same delays and denials that plague private coverage, while supporters frame it as a guardrail against unnecessary spending.

For hospitals and physician groups in the affected states, the vote means WISeR proceeds as planned. Providers should expect new documentation demands and watch closely how vendors handle automated denials, appeals, and the line between flagging waste and blocking legitimate care.

More in Government

Government

Democrats Float 'Medicare for Kids' Ahead of 2026 Midterms

Democrats are floating a narrower "Medicare for Kids" proposal alongside the broader Medicare for All push as healthcare shapes the 2026 midterm debate.

Why it matters: The direction of Democratic healthcare policy could reshape coverage, reimbursement, and payer dynamics across the industry depending on 2026 election outcomes.

Government

BIO Sues to Block Medicare Peer-Country Drug Pricing Pilot

BIO has sued to block a Medicare pilot that ties certain US drug prices to peer-country benchmarks, the latest challenge to Trump's most-favored-nation pricing push.

Why it matters: The outcome will shape how far the federal government can use Medicare pilots to push US drug prices toward what other countries pay.

Government

CMS Finalizes 2.4% Home Health Pay Bump for 2027

CMS finalized a 2.4% home health payment increase for 2027 while tightening Medicare provider enrollment rules to fight fraud.

Why it matters: The rule sets 2027 reimbursement for home health agencies and raises compliance stakes as CMS cracks down on fraud.